Weinstein, Cindy
Jordan, Karin
Green, Stuart
Khanani, Saleem
Beckford-Brathwaite, Elizabeth
Vallejos, Waldimir
Pong, Annpey
Noga, Stephen J.
Rapoport, Bernardo L.
Funding for this research was provided by:
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (N/A)
Article History
Received: 22 August 2019
Accepted: 4 August 2020
First Online: 25 September 2020
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants included in the study. The protocol was approved by institutional review boards or ethics committees at all sites (names listed in Additional file InternalRef removed).
: Not applicable.
: Dr. Weinstein is an employee of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, and is a stockholder in Merck & Co., Inc., Kenilworth, NJ, USA. Dr. Jordan served as an advisor for Merck Sharp & Dohme Corp., Amgen, Hexal, Riemser, Helsinn, Tesaro, Kreussler, Voluntis, Pfizer, Pomme-med, Pharma Mar, Prime Oncology, OnkoUpdate, <i>Annals of Oncology</i>, and UpToDate. Dr. Green is an employee of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, and is a stockholder in Merck & Co., Inc., Kenilworth, NJ, USA. Dr. Khanani has nothing to disclose. Dr. Beckford-Brathwaite was an employee of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. Dr. Vallejos is an employee of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, and is a stockholder in Merck & Co., Inc., Kenilworth, NJ, USA. Dr. Pong is an employee of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, and is a stockholder in Merck & Co., Inc., Kenilworth, NJ, USA. Dr. Noga is now an employee of Takeda Oncology. Dr. Rapoport served as an advisor for Merck Sharp & Dohme Corp., Tesaro, and Heron Therapeutics, and acted on speakers’ bureaus for Merck Sharp & Dohme Corp., Roche, and Tesaro, and received a research grant from Tesaro.